“We are extremely excited to be able to offer a Cherenkov imaging system to the field of Radiation Oncology, where we believe it can change the paradigm of radiation delivery verification and provide intuitive visualization of the treatment for everyone in the department.”

~Dr. Brian Pogue, Professor of Engineering Science at the Thayer School, Dartmouth College, and Professor of Surgery at the Geisel School of Medicine

BeamSite Research

Similar to BeamSite, BeamSite Research provides real-time imaging of radiation delivery. BeamSite Research is designed for research purposes, which is why it is tripod mountable, movable, and has customizable acquisition settings for running imaging tests.

BeamSite Research is a radiotherapy verification camera and software system for its users to capture real-time video of every fraction of radiation being delivered.

Imaging

  • Image Format 1600 X 1200, 12 bit

  • Field of View 45 X 45 cm [typical]

  • Effective Resolution 0.5 mm [typical]

  • Frame Rate Up to 60 FPS

  • LINAC Sync Rate Up to 400 Hz

  • Image Processing Real-Time FPGA

  • Interface USB3, Gen<I>Cam

Features

  • Real-time video of surface dose

  • Use with room lights on

  • Wireless triggering

  • Intrafraction and plan comparison

  • Imaging of patient anatomy

  • Cumulative intensity calculation

  • Integration with treatment plan files, isocenter registration, and QA

  • Customizable acquisition settings

  • Tripod or ceiling mounted

  • Video processing, ROI analysis, video export, inter-fraction comparison, and more!

The Breakthrough 

When the New York Times published a series of articles in 2010 exposing safety concerns surrounding radiation therapy, Dr. Brian Pogue knew it was time to take action. Now the co-founder of DoseOptics, Dr. Pogue set out to make radiotherapy safer, collecting an expert group of researchers and collaborators to assist him.

Together, Dr. Pogue’s team developed a way to visualize EBRT by taking advantage of  the Cherenkov effect, which was named after the scientist and 1958 Nobel Prize winner Pavel Cherenkov. Financed by a series of grants from the National Cancer Institute (NCI) at the National Institutes of Health (NIH), their discovery and development occurred at the Thayer School of Engineering at Dartmouth. They continued to refine it through clinical testing and research at the Norris Cotton Cancer Center located in the Dartmouth-Hitchcock Medical Center.

The work has led to the product BeamSite, a medical imaging system cleared by the FDA for sale in the US, and have been successfully deployed at leading academic and clinical institutions.

FAQs

  • When tissue is irradiated with high energy photons (or electrons) during radiotherapy, it will glow with visible light due to the Cherenkov effect. Although extremely dim, this light can be seen with BeamSite Research, which has been designed specifically to image Cherenkov light in radiotherapy treatment rooms.

  • Schedule a meeting here to learn more about BeamSite Research.

  • Yes. BeamSite offers real-time monitoring and is cleared for use only with photon external beam radiotherapy, anywhere on a patient’s body.

  • Yes. BeamSite Research works by imaging synchronously with the linear accelerator, thereby minimizing the impact of room light.

  • Yes! Please schedule one with us here.

Request a Meeting

Ready to see the power of BeamSite in action? We’d love to connect with you, show you how it works, and answer any questions you may have.